We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA should require premarket review for transvaginal surgical mesh used to repair pelvic organ prolapse (POP), an agency advisory panel recommends.